Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 269 matches for

Professor Faith Osier's TED talk, accepted in April 2018, is now published as one of few by the TED Fellows Talks. The malaria vaccine was invented more than a century ago, yet each year hundreds of thousands of people still die from the disease. How can we improve this vital vaccine? In this informative talk, Faith shows how she combines cutting-edge technology with century-old insights in the hopes of creating a new vaccine that would eradicate malaria once and for all.

Enhancing neonatal care in Kenya: insights from the HIGH-Q exchange stakeholder forum

The Harnessing Innovation in Global Health for Quality Care Exchange (The HIGH-Q Exchange) held a stakeholder meeting during the Kenya Paediatric Association conference between 8th and 11th April 2025, in Mombasa. The project shared key findings on how health systems can go beyond training and equipment to deliver high-quality newborn care. The meeting provided a platform for reflection on how to enhance the quality of neonatal care in Kenyan hospitals, focusing on the role of Ward Assistants in improving care delivery.

KEMRI signs landmark partnership with Wellcome and Oxford

The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.

Lower-dose yellow fever vaccine as effective as the current standard

In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.

Breaking Barriers: Dr Caroline Tigoi’s Journey in Science and Research

The science field has largely been male-dominated from time immemorial and women in science are increasingly making their mark and breaking barriers through conducting and leading various ground-breaking research. The International Day of Women and Girls in Science is an annual observance in recognition of the critical role played by women and girls in science and the promotion of their full and equal access to participation in Science, Technology, Engineering and Mathematics fields. At KWTRP we celebrate, Dr Caroline Tigoi a dedicated scientist whose journey into microbiology and infectious disease research has not only advanced medical science but also inspired the next generation of women in STEM.

Launch of largest-ever study tracking chikungunya burden in East Africa

A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.

KEMRI renews collaboration with Oxford University and Wellcome Trust

The Kenya Medical Research Institute (KEMRI) has signed a seven-year memorandum of agreement with the Wellcome Trust and the University of Oxford. Under this collaboration, Wellcome has awarded £91 million (KES 15 billion) to support research over the next seven years. KEMRI have been collaborating with the Wellcome Trust and the University of Oxford on improving health through research for over 35 years.

Rift Valley fever vaccine to enter Phase II clinical trials in Kenya

A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).

Improving survival rates of children with sickle cell disease in Kenya

Research on sickle cell disease conducted by KEMRI-Wellcome Trust Research Programme (KWTRP) at the Nuffield Department of Medicine shows significant progress in understanding how to improve survival rates and quality of life for those living with the condition.

Hydroxychloroquine provides moderate COVID-19 prevention, large clinical trial shows

Four years after being derailed by scientific fraud and politicised science in the first year of the pandemic, COPCOV, the world’s largest COVID-19 chemoprevention study, finally published results today that showed that hydroxychloroquine (HCQ) does have a moderate benefit in preventing COVID-19.

KWTRP exhibits at the Kenya National Research Festival 2024

KEMRI-Wellcome Trust Research Programme (KWTRP) hosted an exhibition as part of the British High Commission Pavilion during the Kenya National Research Festival 2024. Under the theme “Research Partnerships and collaborations for Socio-Economic Transformation” the festival aimed to raise awareness about the diverse spectrum of research activities in Kenya and internationally encouraging collaboration.

Seven CTMGH researchers awarded full professorships

We are delighted to announce that seven of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Visit MalariaWorld

The Malariaworld exhibition was developed in conjunction with World Malaria Day 2024 to raise awareness of malaria and malaria research, and to highlight some of our contributions to malaria research. You can now visit our virtual exhibition!

KWTRP Annual Policy Engagement Forum

The KEMRI Wellcome Trust Research Programme (KWTRP) hosted its annual policy engagement forum in Nairobi. This year’s forum provided a valuable platform for deliberation between policy stakeholders and researchers, focusing on their research needs and policy priorities. The event is part of a larger consultative process towards the development of the KWTRP strategic plan.

Associate Professors 2024

We are pleased to announce that six of our researchers have been awarded the title Associate Professor

Improving pneumonia recovery in malnourished African children

A project by the KEMRI Wellcome Trust Research Programme (KWTRP) at NDM highlighted the importance of future trials focussing on high-risk, undernourished children and using feeds tailored to their metabolic needs.

The KEMIS Project at KWTRP

Serosurveillance remains a valuable yet underutilized tool. Through the KEMIS project, KWTRP aim to demonstrate the value of multi-pathogen serosurveillance in Kenya.

Celebrating World Malaria Day 2024

On this World Malaria Day 2024, Professor Marta Maia from the KEMRI Welcome Trust Research Programme in Kilifi, Kenya, talks about her research work and shares her reflections on climate change and what this means to vector biology and current interventions.

Visit our exhibition: Malariaworld

The Malariaworld exhibition has been developed for World Malaria Day 2024 to raise awareness of malaria and malaria research. We highlight some of the Nuffield Department of Medicine’s contributions to malaria research. Come and visit our exhibition at the John Radcliffe Academic Centre, 22-29 April 2024.

NEWRISK project awarded RIGHT 5 NHIR funding

Led by Benjamin Tsofa and Jacob McKnight, the project named "A Novel Extreme Weather Risk Insurance System for Kenya (NEWRISK)” will focus on using the latest methods to provide focused data on extreme weather, population vulnerability, and health system capacity readiness across various climatic zones in Kenya.

School Leavers Attachment Scheme

KWTRP hosted 153 students for the Annual School Leavers Attachment Scheme (SLAS) Open Day. The SLAS open day targets top performing students in Kilifi to give them an opportunity to information from various stakeholders and scientists that would help them firm up or redefine their career aspirations. It is an opportunity to give the students information about the need to take science and health related careers with the focus on creating the next pool of researchers in Kenya, Africa and beyond.

Load More

Similar stories